Bibliography
Raja Kandaswamy, M.D.

Return to Dr. Kandaswamy's CV

PUBLICATIONS, PEER-REVIEWED

1. Kandaswamy R, Kamps M, Matas AJ.  “Administration of OKT3 as a two-hour infusion does not attenuate first dose side effects.”  Transplantation.  Sep 15 1999, 68(5): 709-10.

2. Humar A, Hassoun A, Kandaswamy R, Payne WD, Sutherland DER, Matas AJ.  “Immunologic factors:  the major risk factor for decreased long-term renal allograft survival.”  Transplantation.  Dec 27 1999;68(12):1842-1846.

3. Humar A, Kandaswamy R, Granger D, Gruessner RW, Gruessner AC, Sutherland DER.  “Decreased surgical risks of pancreas transplantation in the modern era.”  Annals of Surgery.  Feb 2000;231(2):269-75.

4. Humar A, Parr E, Drangstveit MB, Kandaswamy R, Gruessner AC, Sutherland DER.  “Steroid withdrawal in pancreas transplant recipients.”  Clinical Transplantation.  Feb 2000;14(1):75-8.

5. Humar A, Kandaswamy R, Drangstviet M, Parr E, Gruessner AC, Sutherland DER.  “Prolonged preservation time increases the risk of surgical complications in pancreas transplantation.”  Surgery.  May 2000;127(5):545-51.

6. Humar A, Kandaswamy R, Drangstveit MB, Parr E, Gruessner AC, Sutherland DER.  “Surgical risks and outcome of pancreas transplants.”  Surgery.  June 2000;127(6):634-40.

7. Matsumoto S, Kandaswamy R, Sutherland DER, Hassoun A, Hiraoka K, Sageshima J,  Shibata S, TaniokaY, Kuroda Y.  "Clinical application of the two-layer (University of Wisconsin solution [UW] / perfluorocarbons [PFC]) method of pancreas preservation before transplantation.”  Transplantation.  Sep 15 2000;70(5):771-4.

8. Humar A, Sutherland DER, Ramcharan T, Gruessner RW, Gruessner AC, Kandaswamy R.  “Optimal timing for a pancreas transplant after a successful kidney transplant.”  Transplantation.  Oct 27 2000;70(8):1247-50.

9. Kandaswamy R, Humar A, Payne WD, Dunn DL, Sutherland DE, Matas AJ.  “Risk factors for kidney transplant acute rejection: a multivariate analysis.  Transplant Proc.  Feb-Mar 2001;33(1-2):1112.

10. Sutherland DER, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, Mauer SM, Kennedy WR, Goetz FC, Robertson RP, Gruessner AC, Najarian JS.  “Lessons learned from more than 1,000 pancreas transplants at a single institution.”  Annals of Surgery.  Apr 2001;233(4):463-501.

11. Matas AJ, Payne WD, Sutherland DER, Humar A, Gruessner RW, Kandaswamy R, Dunn DL, Gillingham K, Najarian JS.  “2500 living donor kidney transplants: a single-center experience.”  Annals of Surgery.  Aug 2001;234(2):149-64.

12. Moss A, Najarian JS, Sutherland DER, Payne WD, Gruessner RW, Humar A, Kandaswamy R, Gillingham K, Dunn DL, Matas AJ.  “5000 kidney transplants – a single-center experience.”  Clin Transpl. 2000;159-71.

13. Gruessner RW, Kandaswamy R, Denny R.  “Laparoscopic simultaneous nephrectomy and distal pancreatectomy from a live donor.”  Journal of the American College of Surgeons. Sep 2001;193(3):333-7.

14. Humar A, Ramcharan T, Kandaswamy R, Matas A, Gruessner RW, Gruessner AC, Sutherland DE.  “Pancreas after kidney transplants.”  Am J Surg.  Aug 2001;182(2)155-61.

15. Gruessner AC, Sutherland DER, Dunn DL, Najarian JS, Humar A, Kandaswamy R, Gruessner RW.  “Pancreas after kidney transplants in posturemic patients with type 1 diabetes mellitus.”  J Am Soc Nephrol.  Nov 2001;12(11):2490-9.

16. Matas AJ, Humar A, Kandaswamy R, Payne WD, Gruessner RW, Sutherland DER.  “Kidney and pancreas transplantation without a crossmatch in select circumstances – it can be done.”  Clinical Transplantation.  Aug 2001;15(4):236-9.

17. Matas AJ, Ramcharan T, Paraskevas S, Gillingham K, Dunn DL, Gruessner RW, Humar A, Kandaswamy R, Najarian JS, Payne WD, and Sutherland DER.  “Rapid discontinuation of steroids in living donor kidney transplantation:  a pilot study.”  American Journal of Transplantation.  Sep 2001;1(3):278-83.

18. Humar A, Ramcharan T, Sielaff TD, Kandaswamy R, Gruessner RW, Lake JR, Payne WD.  “Split liver transplantation for two adult recipients: an initial experience.” American Journal of Transplantation.  Nov 2001;1(4):366.

19. Matas AJ, Humar A, Gillingham KJ, Payne WD, Gruessner RW, Kandaswamy R, Dunn DL, Najarian JS, Sutherland DER.  “Five preventable causes of kidney graft loss in the 1990s:  a single-center analysis.”  Kidney International.  Aug 2002;62(2): 704-714.

20. Hiraoka K, Kuroda Y, Suzuki Y, Fujino Y, Tanioka Y, Matsumoto S, Sakai T, Kandaswamy R, Sutherland DE.  “Outcomes in clinical pancreas transplantation with the two-layer cold storage method versus simple storage in University of Wisconsin solution.”  Transplant Proc.  Nov 2002;34(7):2688-9.

21. Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ.  “Risk factors for slow graft function after kidney transplant: a multivariate analysis.” Clinical Transplantation.  Dec 2002;16(6):425-9.

22. Hering B, Matsumoto I, Sawada T, Nakano M, Sakai T, Kandaswamy R, Sutherland DER.  “Impact of two-layer pancreas preservation on islet isolation and transplantation.  Transplantation Dec 27 2002;74(12):1813-6.

23. Paraskevas S, Kandaswamy R, Humar A, Gillingham K, Gruessner RW, Payne WD, Najarian JS, Dunn DL, Sutherland DER, Matas AJ.  “Predicting long-term kidney graft survival: can new trials be performed?”  Transplantation Apr 27 2003, 75(8): 1256-9.

24. Khwaja K, Wijkstrom M, Gruessner AC, Sutherland DER, Humar A, Kandaswamy R, Gruessner RW.  “Pancreas transplantation in crossmatch-positive recipients.”  Clin Transplant, Jun 2003;17(3):242-248.

25. Humar A, Khwaja K, Ramcharan T, Asolati M, Kandaswamy R, Gruessner RW, Sutherland DER, Gruessner AC.  “Chronic rejection: the next major challenge for pancreas transplant recipients.”  Transplantation.  Sep 27 2003;76(6):918-23.

26. Kandaswamy R, Humar A, Khwaja K, Asolati M, Harmon J, Gillingham K, Matas AJ.  “Study 1: A prospective, randomized study of cyclosporine-mycophenolate mofetil versus tacrolimus-sirolimus with rapid discontinuation of prednisone.”  Transplantation Reviews.  Oct 2003;17(4).

27. Hering BJ, Kandaswamy R, Harmon JV, Ansite JD, Clemmings SM, Sakai T, Paraskevas S, Eckman PM, Sageshima J, Nakano M, Sawada T, Matsumoto I, Zhang HJ, Sutherland DER, Bluestone JA.  “Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody.”  American Journal of Transplant Mar 2004;4(3): 390-401.

28. Humar A, Ramcharan T, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  “The impact of donor obesity on outcomes after cadaver pancreas transplants.”  Am J Transplant. Apr 2004;4(4):605-10.

29. Tan M, Kandaswamy R, Sutherland DER, Gruessner RW, Gruessner AC, Humar A.  “Risk factors and impact of delayed graft function after pancreas transplants.”  Am J Transplant. May 2004;4(5):758-62.

30. Khwaja K, Asolati M, Harmon J, Melancon J, Dunn T, Gillingham K, Kandaswamy R, Humar A, Gruessner R, Payne W, Najarian J, Dunn D, Sutherland D, Matas AJ.  “Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients.” Am J Transplant. Jun 2004;4(6):980-7.

31. Sutherland DER, Gruessner R, Kandaswamy R, Humar A, Hering B, Gruessner A.  “Beta Cell Replacement Therapy (pancreas and islet transplantation) for Treatment of Diabetes Mellitus: an integrated approach.”  Transplant Proc. Jul-Aug 2004;36(6):1697-9.

32. Matas AJ, Kandaswamy R, Humar A, Payne WD, Dunn DL, Najarian JS, Gruessner RW, Gillingham KJ, McHugh LE, Sutherland DER.  “Long-term immunosuppression, without maintenance prednisone, after kidney transplantation.”  Ann. Surg.  Sep 2004;240(3):510-6, discussion 516-7.

33. Matsumoto I, Sawada T, Nakano M, Sakai T, Liu B, Ansite J, Zhang H, Kandaswamy R, Sutherland DER, Hering BJ.  “Improvement in islet yield from obese donors for human islet transplants.”  Transplantation.  Sep 27 2004;78(6):880-5.

34. Humar A, Ramcharan T, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  “Technical failures after pancreas transplants: why grafts fail and the risk factors – a multivariate analysis.”  Transplantation.  Oct 27 2004;78(8):1188-92.

35. Khwaja K, Asolati M, Harmon J, Melancon JK, Dunn TB, Gillingham KJ, Kandaswamy R, Humar A, Gruessner RW, Payne WD, Najarian JS, Dunn DL, Sutherland DER, Matas AJ.  “Rapid discontinuation of prednisone in higher-risk kidney transplant recipients.”  Transplantation.  Nov 15 2004;78(9):1397-9.

36. Kandaswamy R.  “Laparoscopic vs open nephrectomy in 210 consecutive patients: outcomes, cost, and changes in practice patterns.”  Surg Endosc.  Nov 2004;18(11):1684.

37. Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey J, Hunter DW, Sutherland DER.  “Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.”  JAMA.  Feb 16 2005;293(7): 830-5.

38. Nath DS, Gruessner AC, Kandaswamy R, Gruessner RW, Sutherland DER, Humar A.  “Late anastomotic leaks in pancreas transplant recipients – clinical characteristics and predisposing factors.”  Clinical Transplanationt, Apr 2005;19(2): 220-4.

39. Humar A, Carolan E, Ibrahim H, Horn K, Larson E, Glessing B, Kandaswamy R, Gruessner RW, Lake J, Payne WD.  “A comparison of surgical outcomes and quality of life surveys in right lobe vs. left lateral segment liver donors.”  Am J Transplant, Apr 2005;5(4 Pt 1): 805-9.

40. Challacombe B, Kandaswamy R, Dasgupta P, Mamode N.  “Telementoring facilities independent hand-assisted laparoscopic living donor nephrectomy.”  Transplant Proceedings.  Mar 2005;37(2):613-6.

41. Nath DS, Kandaswamy R, Gruessner RW, Sutherland DER, Dunn DL, Humar A.  “Fungal infections in transplant recipients receiving alemtuzumab.”  Transplant Proceedings, Mar 2005;37(2):934-6.

42. Gruessner RW, Kandaswamy R, Humar A, Gruessner AC, Sutherland DER.  “Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation.”  Tranplantation. May 15 2005;79(9):1184-9.

43. Kandaswamy R, Melancon JK, Dunn T, Tan M, Casingal V, Humar A, Payne WD, Gruessner RW, Dunn DL, Najarian JS, Sutherland DER, Gillingham KJ, Matas AJ.  “A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients—an interim analysis.”  Am J Transplant.  June 2005;5(6):1529-36.

44. Kandaswamy R. “Laparoscopic vs open nephrectomy in 210 consecutive patients: outcomes, cost, and changes in practice patters.”  Surg Endosc.  Nov 2004;18(11):1684.

45. Tan M, Kandaswamy R,  Sutherland DER, Gruessner RW.  “Laparoscopic donor distal pancreatectomy for living donor pancreas and pancreas-kidney transplantation.”  Am J Transplant.  Aug 2005;5(8):1966-70.

46. Matas AJ, Kandaswamy R, Gillingham KJ, McHugh L, Ibrahim H, Kasiske B, Humar A.  “Prednisone-free maintenance immunosuppression – a 5-year experience.”  Am J Transplant.  Oct 2005;5(10):2473-8.

47. Paraskevas S, Coad JE, Gruessner A, Kandaswamy R, Humar A, Sutherland DER, Gruessner RW.  “Posttransplant lymphoproliferative disorder in pancreas transplantation: a single-center experience.”  Transplantation.  Sep 15 2005;80(5):613-22.

48. Nath DS, Gruessner AC, Kandaswamy R, Gruessner RW, Sutherland DER, Humar A.  “Outcomes of pancreas transplants for patients with type 2 diabetes mellitus.”  Clin Tranpslant.  Dec 2005;19(6):792-7.

49. Kandaswamy R, Sutherland DER.  “Pancreas versus islet transplantation in diabetes mellitus: How to allocate decreased donor pancreata?”  Transplant Proc.  Mar 2006;38(2):365-7.

50. Kandaswamy R, Kasiske B, Ibrahim H, Matas AJ.  “Living or deceased donor kidney transplants for candidates with significant extrarenal morbidity.”  Clinical Transplant.  May-June 2006;20(3):346-50.

51. Shapiro J, Ricordi C, Hering B, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel M, Berney T, Brennan D, Cagliero E, Alejandro R, Ryan E, DiMercurio B, Morel P, Polonsky K, Reems J, Bretzel R, Bertuzzi F, Froud T, Kandaswamy R, Sutherland D, Eisenbarth G, Segal M, Preksaitis J, Korbutt G, Barton F, Viviano L, Seyfert V, Bluestone J, Lakey J.  “International trial of the Edmonton protocol for islet transplantation.”  New England Journal of Medicine.  Sep 28 2006;355(13):1318-30.

52. Paraskevas S, Kandaswamy R, Humar A, Gillingham KJ, Gruessner RW, Payne WD, Najarian JS, Sutherland DE, Matas AJ.  “Risk factors for rising creatinine in renal allografts with 1 and 3 yr survival.” Clin Transplant. Nov-Dec 2006;20(6):667-72.

53. Matas AJ, Kandaswamy R.  “The current role of calcineurin inhibitors in posttransplant immunosuppression?”  Am J Transplant.  Dec 2006;6(12):2827-9.

54. Adrogue H, Matas AJ, McGlennon RC, Key NS, Gruessner AC, Gruessner RW, Humar A, Sutherland DER, Kandaswamy R.  “Do inherited hypercoagulable states play a role in thrombotic events affecting kidney/pancreas transplant recipients?”  Clinical Transplantation.  Jan-Feb 2007;21(1):32-7.

55. Kandaswamy R, Humar A, Casingal V, Gillingham K, Ibrahim H, Matas AJ.  “Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.”  Transplantation.  Mar 007;83(6):722-6.

56. Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A.  “Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode.”  Am J Transplant.  Aug 2007;7(8):1948-53.

57. Humar A, Crotteau S, Gruessner AC, Kandaswamy R, Gruessner RW, Payne WD, Lake J.  “Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and posttransplant diabetes.”  Clinical Transplantation.  Jul-Aug 2007; 21(4):526-31.

58. Gruessner RW, Sutherland DE, Kandaswamy R, Gruessner AC. Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. Transplantation. 2008 Jan 15;85(1):42-7.

59. Wang SN, Sturdevant M, Kandaswamy R, Gruessner RG, Sutherland DE, Humar A. Technical failure of the pancreas after SPK transplant: are these patients good candidates for later pancreas retransplant? Clin Transplant. 2008 Jan-Feb;22(1):50-4.

60. Matas AJ, Gillingham KJ, Humar A, Ibrahim HN, Payne WD, Gruessner RW, Dunn TB, Sutherland DE, Najarian JS, Kandaswamy R. Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome. Transplantation. 2008 Feb 15;85(3):338-43.

61. Gruessner RW, Sutherland DE, Drangstveit MB, Kandaswamy R, Gruessner AC. Pancreas allotransplants in patients with a previous total pancreatectomy for chronic pancreatitis. J Am Coll Surg. 2008 Mar;206(3):458-65. Epub 2007 Nov 12.

62. Hill M, Garcia R, Dunn T, Kandaswamy R, Sutherland DE, Humar A.  What happens to the kidney in an SPK transplant when the pancreas fails due to a technical complication?  Clin Transplant.  2008 Mar 3 [Epub ahead of print].

63. Kandaswamy R, Humar A, Dunn T, Sutherland D.  Can we maintain immunosuppression avoiding nephrotoxic agents in pancreas transplantation?  Transplantation Proceedings.  2008 Mar; 40(2):516-7.

64. Whitson BA, Asolati M, Kandaswamy R, Sutherland DE. Diabetic gastroparesis-associated bezoar resolution via “cola-lysis.” Clin Transplant. 2008 March-Apr 22(2):242-4.

65. Humar A, Beissel J, Crotteau S, Kandaswamy R, Lake J, Payne W.  Whole liver versus split liver versus living donor in the adult recipient – an analysis of outcomes by graft type.  Transplantation.  2008 May 27;85(10):1420-4.

Top of page

PUBLICATIONS, NON PEER-REVIEWED

1. Kandaswamy R. “Hospital Master.” Hospital database management software independent publication, 1989.

2. Kandaswamy R, Stillman A, Granger D, Sutherland DER, Gruessner RW.  “MRI is superior to angiography in the evaluation of living related simultaneous kidney pancreas donors.” Transplantation Proceedings. Feb-Mar 1999;31(1-2):604-5.

3. Kandaswamy R, Humar A, Gruessner AC, Harmon JV, Granger DK, Lynch S, Sutherland DER, Gruessner RW.  “Vascular graft thrombosis after pancreas transplantation – comparison of the FK 506 and cyclosporine eras.”  Transplantation Proceedings.  Feb-Mar 1999;31(1-2):602-3.

4. Humar A, Harmon J, Gruessner AC, Kandaswamy R, Granger D, Zheng C, Drangstveit MB, Sutherland DER, Gruessner RW.  “Surgical complications requiring early relaparotomy after pancreas transplantation:  comparison of the cyclosporine and FK 506 eras.”  Transplantation Proceedings.  Feb-Mar 1999;31(1-2):606-7.

5. Kandaswamy R, Sutherland DER, Humar A, Payne WD, Gruessner RW, Matas AJ.  “Transplantation without a final crossmatch – it can be done.”  Transplantation Proceedings.  Feb-Mar 2001;33(1-2):1234.

6. Kandaswamy R, Gillingham K, Humar A, Payne WD, Dunn DL, Sutherland DER, Najarian JS, Matas AJ.  “Impact of HLA-ABDR math on chronic rejection in kidney transplants.” Transplantation Proceedings.  2001;33(1-2):1292.

7. Kandaswamy R, Humar A, Payne WD, Dunn DL, Sutherland DER, Matas AJ.  “Risk factors for kidney transplant acute rejection:  a multivariate analysis.”  Transplantation Proceedings.  2001;33(1-2):1112.

8. Sutherland DER, Gruessner RW, Humar A, Kandaswamy R, Najarian JS, Dunn DL, Gruessner AC.  “Pretransplant immunosuppression for pancreas transplants alone in nonuremic diabetics.”  Transplantation Proceedings.  Feb-Mar 2001;33(1-2):1656-8.

9. Kandaswamy R, Matas AJ.  “Laparoscopic donor nephrectomy:  The University of Minnesota experience.”  Minnesota Medicine.  Dec 2001;84(12):43-5.

10. Hiraoka K, Kuroda Y, Suzuki Y, Fujino Y, Tanioka Y, Matsumoto S, Sakai T, Kandaswamy R, Sutherland DER.  “Outcomes in clinical pancreas transplantation with the two-layer cold storage method versus simple storage in University of Wisconsin solution.”  Transplant Proceedings Nov 2002;34(7):2688-9.

Top of page

BOOK CHAPTERS

1. Moss A, Najarian JS, Sutherland DER, Payne WD, Gruessner RW, Humar A, Kandaswamy R, Gillingham K, Dunn DL, Matas AJ.  “5000 Kidney Transplants – A Single-Center Experience.”  Clinical Transplants 2000, UCLA Immunogenetics Center, 2000.

2. Kandaswamy R, Dunn DL.  “Critical Care of the pancreas transplant recipient.”  Manual of Intensive Care Medicine, 3rd edition.  Editors Irwin & Rippe.  Lippincott, Williams, & Wilkins. 2001.

3. Kandaswamy R.  “Pancreas preservation.”  Transplantation of the Pancreas.  Gruessner RW, ed.  Springer-Verlag, New York.  2002. 

4. Kandaswamy R, Sutherland DER.  “Critical care of the pancreas transplant recipient.”  Manual of Intensive Care Medicine, 5th edition.  Editors, Editors Irwin & Rippe.  Lippincott, Williams, & Wilkins. 2002.

5. Kandaswamy R, Humar A.  “Operative Procedures for Donors and Recipients.” Manual of Kidney Transplant Medical Care.  Editor, Arthur Matas.  Fairview Publications, 2003.

6. Kandaswamy R.  “The Recipient – Selection and Work Up.” Living Donor Organ Transplantation.  Editor, Rainer Gruessner, Associate Editor:  Enrico Benedetti, M.D.  The McGraw-Hill Companies, New York, New York.  Anticipated publication date:  July or August, 2007

7. Kandaswamy R.  “The Recipient – Perioperative Management, Immunosuppressive Therapy, and Post-Transplant Complications.”  Living Donor Organ Transplantation.  Editor, Rainer Gruessner, Associate Editor:  Enrico Benedetti, M.D.  The McGraw-Hill Companies, New York, New York.  Anticipated publication date:  July or August, 2007

8. Kandaswamy R., Sutherland, D.E.R.  “Pancreatic Transplantation.”  Civetta, Taylor, and Kirby’s Handbook of Critical Care, 4th Edition.  Editor, Mihae Yu.  Lippincott, Williams, & Wilkins.  In press.

9. Humar A, Dunn T, Kandaswamy R, Payne WD, Sutherland DER, Matas AJ.  “Ch. 5: Steroid-Free Immunosuppression in Kidney Transplant Recipients: The University of Minnesota Experience.”  Clinical Transplants 2007.  J. Michael Cecka, Paul I Terasaki, eds.  Terasaki Foundation Laboratory, Los Angeles, California.  June 2008.

Top of page

ORAL PRESENTATIONS

1. “Vascular graft thrombosis after pancreas transplantation – comparison of the FK vs. CsA era.” Kandaswamy R, Humar A, Gruessner AC, Granger D, Sutherland DER, Gruessner RW, University of Minnesota. American Society of Transplant Surgeons, Chicago, IL.  May 1998.

2. “Monoclonal antibodies in gram negative sepsis”, Grand Rounds, Department of Surgery, Howard University Hospital, Washington, D.C. Oct 1992.

3. “Techniques in tissue engineering.” Grand Rounds, Department of Surgery, Howard University Hospital, Washington, D.C. Nov. 1993.

4. “Techniques in tissue engineering.” Grand Rounds, Department of Surgery, Howard University Hospital, Washington, D.C. Nov. 1993.

5. “Management of duodenal injuries.”  Washington Regional Trauma Conference, Washington Hospital Center, Washington, D.C. Dec. 1995.

6. “Traumatic carotid jugular fistula in a Vietnam war-wound.” Kandaswamy R, O. Warner National Medical Assn. Scientific Assembly, Chicago, IL. July 1996.

7. “Surgical complications requiring early relaparotomy in pancreas transplantation – comparison of FK vs. CsA era.” Humar A, Harmon J, Gruessner AC, Kandaswamy R, Granger D, Zhang K, Drangstveit MB, Sutherland DER, Gruessner RW, University of Minnesota. 24th Annual Scientific Meeting of the American Society of Transplant Surgeons, Chicago, IL.  May 1998.

8. “Current status of pancreas and islet cell transplantation.” Kandaswamy R Howard University Medical Staff Association, St. Thomas, VI. Invited Speaker –Jan 1998. 

9. “MRI is superior to angiography in the evaluation of living related simultaneous kidney pancreas donors.”  Kandaswamy R, Stillman A, Granger D, Sutherland DER, Gruessner RW, University of Minnesota. 17th Annual Meeting of the American Society of Transplant Physicians, Chicago, IL.  May 1998.

10. “Prolonged preservation time increases the incidence of surgical complications after pancreas transplant.” Kandaswamy R, Hassoun A, Parr E, Zhang K, Gruessner AC, Sutherland DER, Humar A. 25th Annual Scientific Meeting of the American Society of Transplant Surgeons, Chicago, IL May 1999.

11. “Optimal timing for a pancreas transplant after a successful kidney transplant.” Humar A, Kandaswamy R, Hassoun A, Drangstveit MB, Durand B, Gruessner AC, Sutherland DER. 25th Annual Scientific Meeting of the American Society of Transplant Surgeons, Chicago, IL May 1999.

12. “The questionable importance of non-immunologic risk factors in long term kidney graft survival.” Humar A, Hassoun A, Kandaswamy R, Matas AJ   18th Annual Meeting of the  American Society of Transplantation, Chicago, IL May 1999.

13. “The low incidence of PTLD after pancreas and simultaneous pancreas kidney transplants.”  Hassoun A, Humar A, Kandaswamy R, Long A, Manivel C, Drangstveit MB, Matas AJ, Gruessner RW, Sutherland DER  18th Annual Meeting of the American Society of Transplantation, Chicago, IL May 1999.

14. “Daclizumab therapy in solitary & pancreas-kidney transplantation.” Kandaswamy R, Sutherland DER, Humar A, Drangstveit MB, Chmielewski B, Gruessner AC. 7th World Congress of the International Pancreas & Islet Transplant Association, Sydney, Australia. August 1999.

15. “Critical islet mass in islet autotransplantation after pancreas resection.” Kandaswamy R, Hering B, Sutherland DER 7th World Congress of the International Pancreas & Islet Transplant Association, Sydney, Australia. August 1999

16. “Daclizumab (Dmab) therapy in solitary and pancreas (Px)-Kidney(Kd) Transplantation (Tx).”  Kandaswamy R, Sutherland DER, Humar A, Drangstveit MB, Chmielewski B, Gruessner AC. Minneapolis Transplant Congress, Posttransplant Immunosuppression:  New Paradigms.  Minneapolis, October 1999.

17. “Intraoperative daclizumab and thymoglobulin in pancreas transplantation.”  Kandaswamy R, Sutherland DER, Humar A, Drangstveit MB, Gruessner AC. Minneapolis Transplant Congress, Posttransplant Immunosuppression:  New Paradigms.  Minneapolis, October 1999.

18. “Retransplants – markedly improved outcome using CSA-based immunosuppression.”  Kandaswamy R, Matas AJ.  Minneapolis Transplant Congress, Posttransplant Immunosuppression:  New Paradigms.  Minneapolis, October 1999.

19. “Steroid avoidance after living donor (LD) transplantation – a pilot study.”  Ramcharan T, Schoelkoph L, McHugh L, Humar A, Kandaswamy R, Matas AJ.  American Society of Nephrology, 2000.

20. “Pre-emptive simultaneous pancreas kidney (SPK) transplants:  is there any significant advantage?”  Humar A, Kandaswamy R, Drangstveit MB, Papalois B, Gruessner RW, Gruessner AC, Sutherland DER.  American Society of Nephrology, 2000.

21. “Incidence of acute rejection (AR) in living donor kidney transplant recipients with azathioprine and optimization of CSA trough levels.”  Humar A, Kandaswamy R, Payne WD, Gruessner RW, Sutherland DER.  American Society of Nephrology, 2000.

22. “Islet autotransplantation after pancreas resection.” Kandaswamy R, Hering B, Sutherland DER.  First Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

23. “Chronic rejection in pancreas transplant recipients:  a multivariate analysis of risk factors.”  Humar A, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  First Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

24. “The impact (?) of HLA-ABDR match on chronic rejection (CR).”  Matas AJ, Gillingham K, Humar A, Payne WD, Kandaswamy R, Dunn DL, Sutherland DER. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

25. “Critical islet mass in islet autotransplantation (IaTx) after pancreas (Px) resection.”  Kandaswamy R, Hering B, Sutherland DER.  First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

26. “Pancreas (Px) transplantation (Tx) alone (PTA) for non-uremic diabetic patients:  a 20-year experience.”  Sutherland DER, Gruessner RW, Humar A, Kandaswamy R, Najarian JS, Dunn DL, Gruessner AC.  First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

27. “Improved outcome for pancreas after kidney transplantation (PAK).”  Gruessner RW, Sutherland DER, Humar A, Kandaswamy R, Gruessner AC.  First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

28. “Risk factors for kidney transplant acute rejection:  a multivariate analysis.”  Matas AJ, Humar A, Payne WD, Kandaswamy R, Dunn DL, Sutherland DER, Najarian JS.  International Congress of the Transplantation Society, Rome, August 2000.

29. “Pre-transplant immunosuppression for pancreas (Px) transplants (Txs) alone (PTA) in non-uremic diabetic recipients.”  Sutherland DER Gruessner RW, Humar A, Kandaswamy R, Najarian JS, Dunn DL, Gruessner AC.  International Congress of the Transplantation Society, Rome, August 2000.

30. “Steroid avoidance after living donor transplantation – a pilot study.”  Ramcharan T, Schoelkoph L, McHugh L, Humar A, Kandaswamy R, Matas AJ, The American Society of Nephrology 33rd Annual Meeting, Toronto, October 2000.

31. “Risk factors for graft loss differ by post transplant interval.”  Matas AJ, Gillingham K, Kandaswamy R, Humar A, The American Society of Nephrology 33rd Annual Meeting, Toronto, October 2000.

32. “Risk factors for acute rejection (AR) in pancreas transplant recipients:  a multivariate analysis.”  Humar A, Kandaswamy R, Ramcharan T, Paraskevas S, Meirelles R, Gruessner RW, Gruessner AC, Sutherland DER.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

33. “Living kidney donation:  long-term (20-37 yrs.) consequences.”  Ramcharan T, L McHugh, Kandaswamy R, Gruessner RW, Payne WD, Sutherland DER, Humar A, Dunn DL, Najarian JS, Matas AJ.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

34. “Improvements from steroid withdrawal after pancreas transplantation:  1-year results of a prospective, randomized open-label study.”  Gruessner RW, Sutherland DER, Parr E, Humar A, Kandaswamy R, Gruessner AC.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001.

35. “Steroid avoidance (minimization) after kidney transplantation.”  Matas A, Ramcharan T, Paraskevas S, Kandaswamy R, Humar A, Gillingham K.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

36. “Xenogeneic pig islets escape rejection in immunosuppressed primates but fail to sustain normoglycemia.”  Wijkstrom M, Kirchhof N, Pilon K, Kandaswamy R, Clemmings S, Trexler A, Gilmore T, Sutherland DER, Hering B.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

37. “Pancreas after kidney (PAK) vs. simultaneous pancreas kidney (SPK) transplants:  a comparison of waiting times, cost, and quality of life.”  Humar A, Kandaswamy R, Ramcharan T, Paraskevas S, Gruessner RW, Gruessner RW, Gruessner AC, Sutherland DER.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

38. “Insulin independence after single-donor islet transplantation in type 1 diabetes with hOKT3γ-1 (ala-ala), sirolimus, and tacrolimus therapy.”  Hering B, Kandaswamy R,  Harmon J, Ansite J, Clemmings S, Sakai T, Zabloski J, Duderstadt K, Jacobsen K, Gibson C, Paraskevas S, Eckman P, Nakano M, Sawada T, Zhang H, Sutherland DER, Bluestone J.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

39.  “Risk factors for acute rejection (AR) in pancreas transplant recipients:  a multivariate analysis.”  Humar A, Kandaswamy R, Ramcharan T, Paraskevas S, Meirelles R, Gruessner RW, Gruessner AC, Sutherland DER.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

40. “The impact of elderly and pediatric donors on outcome after SPK transplant.” Humar A, Kandaswamy R, Ramcharan T, Paraskevas S, Denny R, Gruessner RW, Gruessner AC, Sutherland DER.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

41. “Analysis of acute and chronic rejection patterns after pancreas transplant alone (PTA).”  Humar A, Kandaswamy R, Ramcharan T, Paraskevas S, Meirelles R, Grussner RW, Gruessner AC.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

42. “Pancreas after kidney (PAK) vs. simultaneous pancreas kidney (SPK) transplants:  a comparison of waiting times, cost, and quality of life.”  Humar A, Kandaswamy R, Ramcharan T, Paraskevas S, Gruessner RW, Gruessner AC, Sutherland DER.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

43. “IFN-γ cytokine gene polymorphisms (CGP) increase risk of rejection in pancreas transplant alone (PTA) recipients.”  Kandaswamy R, Gruessner AC, Hering B, Humar A, Gruessner RW, Bland B, Noreen H, Segall M, Sutherland DER.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

44. “GVHD (grafts versus host disease) in pancreas transplantation – rare yet lethal.”  Wijkstrom M, Sutherland DER, Paraskevas S, Humar A, Gruessner RW, Kandaswamy R.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

45. “IV immunoglobulin decreases refractory anti-A antibody titers and ABO incompatible kidney-pancreas transplant.”  Kandaswamy R, Eastlund T, Denny R, Khwaja K, Humar A, Gruessner RW, Sutherland DER.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

46. “Pancreas Exchange (PEx):  single procedure graft pancreatectomy and retransplant for early graft thrombosis.”  Paraskevas S, Gruessner AC, Kandaswamy R, Humar A, Sutherland DER, Gruessner RW G.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

47. “Kidney (KD) and kidney-pancreas (KP) transplants (Tx) in Jehovah’s Witnesses (JW) – a single-center experience with 50 transplants.”  Kandaswamy R, Ramcharan T, Matas AJ, Gillingham K, Gruessner RW, Humar A, Sutherland DER.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

48. “Pancreas (Px) transplants (Txs) alone (PTA) in non-uremic diabetic recipients with pre-tx immunosuppression (IS).  Sutherland DER, Gruessner RW G, Humar A, Kandaswamy R, Najarian JS, Dunn DL, Gruessner AC.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

49. “Pancreas (Pa) transplants (Txs) with >5 year followup:  a single institution’s experience.”  Gruessner RW, Sutherland DER, Dunn DL, Paraskevas S, Humar A, Kandaswamy R, Gruessner AC.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

50. “Successful single-donor islet transplantation in type-1 diabetes with hOKT3g-1 (ala-ala), sirolimus, and tacrolimus therapy.”  Hering BJ, Harmon JV, Ansite J, Sakai T, Duderstadt K, Jacobsen K, Zhang HJ, Kandaswamy R, Sutherland DER, Bluestone JA.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

51. “Improved glycemic control after intraportal transplantation of adult porcine islets in diabetic immunosuppressed rhesus monkeys.”  Wijkstrom M, Kirchhof N, Pilon KJ, Eckman E, Wahlberg J, Clemmings S, Trexler A, Kandaswamy R, Sutherland DER, Hering BJ.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

52. “A prospective randomized trial of mycophenolate (MMF) vs. sirolimus (SRL) in pancreas after kidney (PAK) transplantation.”  Kandaswamy R, Paraskevas S, Meirelles R, Ramcharan T, Gruessner AC, Humar A, Gruessner RW, Parr E, Sutherland DER.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

53. “Technical failures (TFs) after pancreas transplant – why grafts fail and the risk factors:  a multivariate analysis.”  Humar A, Paraskevas S, Khwaja K, Denny R, Asolati M, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

54. “Optimal timing for pancreas after kidney (PAK) transplants – waiting a long time has a detrimental impact on kidney graft survival.”  Humar A, Ramcharan T, Paraskevas S, Denny R, Khwaja K, Asolati M Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

55. “Transplants from obese pancreas donors – good initial function but increased incidence of surgical complications.”  Humar A, Ramcharan T, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

56. “Split-liver transplants (SLTs) for 2 adult recipients:  the key is proper donor and recipient selection.”  Humar A, Sielaff T, Kandaswamy R, Gruessner RW, Knaak M, Kalis A, Shriver L, Lake J, Payne WD.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

57. “Pre-tx immunosuppression (IS) for pancreas (PX) transplants (TXs) alone (PTA) in non-uremic diabetic recipients.”  Sutherland DER, Gruessner RW, Humar A, Kandaswamy R, Dunn DL, Najarian JS, Gruessner AC.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

58. “New advances in living donor pancreas transplantation including laparoscopic donor hemipancreatectomy.”  Gruessner RW, Sutherland DER, Kandaswamy R, Humar A, Gruessner AC.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

59. “Predicting long-term kidney graft survival – can new trials be done?”  Paraskevas S, Gillingham K, Humar A, Kandaswamy R, Matas AJ.  XIX International Congress of the Transplantation Society, Miami, August 2002.

60. “Steroid withdrawal after pancreas transplantation (Pa Tx): a prospective, randomized, open-label study.”  Gruessner RW, Sutherland DER, Parr E, Humar A, Kandaswamy R, Gruessner AC.  XIX International Congress of the Transplantation Society, Miami, August 2002.

61. “Decreased incidence of hypothermia and peritoneal irritation in laparoscopic donor nephrectomy using a filter-hydrator-heating device [Insuflow®].  Kandaswamy R, Gillingham K, Harmon J, Asolati M.  2003 SAGES Scientific Session and Post Graduate Course, March 2003, Los Angeles.

62.  “A prospective randomized study of cyclosporine (CSA)/CellCept (MMF) vs. tacrolimus (TAC)/sirolimus(SIR) with rapid discontinuation of prednisone (P).  Kandaswamy R, Humar A, Khwaja K, Asolati M, Harmon J, Gillingham K, Matas AJ.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

63. “A prospective, randomized of steroid withdrawal with mycophenolate (MMF) vs. sirolimus (SRL) in pancreas after kidney (PAK) transplants.”  Kandaswamy R, Khwaja K, Gruessner AC, Gruessner RW, Humar A, Glumac E, Sutherland DER.  American Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

64. “Causes of pancreas graft loss in 1500 pancreas transplant (PTx) recipients:  changing pattern over 25 years.”  Humar A, Asolati M, Harmon J, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

65. “Successful single donor islet transplantation in type I diabetes.”  Hering B, Kandaswamy R, Ansite J, Eckman P, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Sutherland DER.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

66. “Left-side pancreas placement: surgical risk or surgical standard?”  Gruessner RW, Sutherland DER, Kandaswamy R, Humar A, Gruessner AC.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

67. “The degree of change in urine amylase after treatment of acute rejection in pancreas transplant recipients is predictive of graft survival.”  Nath D, Asolati M, Gruessner AC, Kandaswamy R, Gruessner RW, Sutherland DER, Humar A.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

68. “Pre-transplant immunosuppression (IS) for pancreas (PX) transplants (Txs) along (PTA) in non-uremic diabetic recipients.”  Sutherland DER, Gruessner RW, Humar A, Kandaswamy R, Dunn DL, Najarian JS, Gruessner AC.  9th International Congress of the International Pancreas and Islet Transplant Association.  Dublin, Ireland.  July 2003.

69. “A Prospective, randomized trial of steroid free maintenance vs. delayed stroid withdrawal using a sirolimus-tacrolimus regimen in simultaneous pancreas-kidney transplants (SPK).   Kandaswamy R, Asolati M, Gruessner AC.  Humar A, Gruessner RW, Pulkrabeck L, Sutherland DER.  9th International Congress of the International Pancreas and Islet Transplant Association.  Dublin, Ireland.  July 2003.

70. “A Prospective, randomized trial of steroid withdrawal with mycophenolate (MMF) vs. sirolimus (SRL) in pancreas after kidney (PAK) transplants.  Kandaswamy R, Khwaja K, Gruessner AC, Gruessner RW, Humar A, Glumac E, Sutherland DER.  9th International Congress of the International Pancreas and Islet Transplant Association.  Dublin, Ireland.  July 2003.

71. “Comparison of acute rejection between whole liver grafts and adult partial living donor grafts and cadaveric split liver grafts.”  Melancon JK, Payne WE, Gruessner RW, Kandaswamy R, Lake JR, Tan M, Gruessner AC, Humar A.  Fifth Annual American Transplant Congress.  Boston, May 2004.

72. “Calcineurin inhibitor (CI) and steroid-free immunosuppression (ImmSx) for pancreas (Px) and Px-Kidney (KD) recipients using Campath for both induction and maintenance (maint.).”  Kandaswamy R, Gruessner RW, Gruessner AC, Humar A, Sutherland DER.  Fifth Annual American Transplant Congress.  Boston, May 2004.

73. “Graft survival analysis in 20 Type 1 diabetic islet allograft recipients.”  Hering B, Kandaswamy R, Parkey J, Duderstadt K, Ansite J,  Zhang HJ, Nakano M, Matsumoto I, Sawada T, Liu B, Bauer A, Guenther L, Jevne R, Gruessner AC, Bluestone J, Sutherland DER.  Fifth Annual American Transplant Congress.  Boston, May 2004.

74. “An initial experience with laparoscopic (LAP) donor distal pancreatectomy for living donor pancreas transplantation.”  Tan M, Kandaswamy R, Gruessner RW.  Fifth Annual American Transplant Congress.  Boston, May 2004.

75. “Conversion to a calcineurin inhibitor (CI) and steroid free regimen after pancreas (Px) transplantation (Tx).  Gruessner RW, Humar A, Kandaswamy R, Gruessner AC, Sutherland DER.  Fifth Annual American Transplant Congress.  Boston, May 2004.

76. “Laparoscopic vs. open donor nephrectomy (ODN) in pediatric (peds) kidney (KD) transplants (Txs).”  Kandaswamy R, Tan M, Humar A, Gruessner RW, Sutherland DER, Matas AJ.  Fifth Annual American Transplant Congress.  Boston, May 2004.

77.  “Prednisone (P)-free maintenance immunosuppression (IS) after kidney transplantation: 92% graft survival at 4 years.”  Humar A, Kandaswamy R, Harmon J, Melancon JK, Dunn DL, Tan M, Matas AJ.  Fifth Annual American Transplant Congress.  Boston, May 2004.

78. “Calcineurin inhibitor-free and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplants.”  Gruessner RW, Kandaswamy R, Dunn TB, Humar A, Gruessner AC, Sutherland DER.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

79. “Living donor (LD) or deceased donor (DD) kidney transplant for the candidate with significant extra-renal disease?”  Kandaswamy R, Gillingham K, Humar A, Matas AJ. Sixth Annual American Transplant Congress.  Seattle, May 2005.

80. “Rapid discontinuation of prednisone (P) after kidney transplantation – the 5 yr. data.”  Humar A, Kandaswamy R, Gillingham K, Payne WD, Dunn TB, Tan M, Casingal V, Sturdevant M, Matas AJ.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

81. “Long-term (>4 yrs) insulin independence after single-donor islet transplantation in type diabetes with hOKT3g-1 (ALA-ALA), sirolimus, and tacrolimus therapy.”  Hering B, Kandaswamy R Parkey J, Ansite J, Sutherland DER, Bluestone J.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

82. “Kidney failure in pancreas transplant alone (PTA) recipients – what is the incidence and the risk factors?”  Humar A, Kandaswamy R, Dunn TB, Casingal V, Tan M, Sturdevant M, Gruessner RW, Matas AJ, Sutherland DER, Gruessner AC.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

83. “Prospective Randomized Trial of Maintenance Immunosuppression (IS) in Prednisone (P)-Free Recipients: Mixed Results.”  Kandaswamy R, Humar A, Sturdevant M, Garcia-Roca R, Casingal V, Tan M, Nguyen T, Gillingham K, Matas AJ.  First Annual World Transplant Congress.  Boston, July 2006.

84. “What Happens to the Kidney Graft of a SPK Transplant When Pancreas is Lost Due to a Technical Complication.”   Humar A, Garcia R, Gross E, Sturdevant M, Nguyen T, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  First Annual World Transplant Congress.  Boston, July 2006.

85. “6 Years of Prednisone (P)-Free Maintenance Immunosuppression.”  Humar A, Kandaswamy R, Payne WD, Gruessner RW, Sutherland DER, Kasiske B, Ibrahim H, Spong R, Gillingham K, Matas AJ.  First Annual World Transplant Congress.  Boston, July 2006.

86. “Cardiovascular Risk Factor After Kidney Tranpslant with Prednisone (P)-Free Maintenance Immunosuppression: A Comparison of 3 Protocol.”  Garcia-Roca R, Sturdevant M, Gross E, Humar A, Kandaswamy R, Gillingham K, Cohen M, Matas AJ.  First Annual World Transplant Congress.  Boston, July 2006.

87. “Why Should Maintenance Steroids be Intoduced in Patients Treasures Acute Rejection (AR) on a Steroid Avoidance Regimen?”  Humar A, Gillingham K, Kandaswamy R, Payne WD, Matas AJ.  First Annual World Transplant Congress.  Boston, July 2006.

88. “Pancreas after Kidney (PAK) Tx in Patients on Prednisone (P)-Free Maintenance Immunosuppression (IS).”  Casingal V, Sturdevant M, Sutherland DER, Kandaswamy R, Gruessner RW, Humar A, Gillingham K, Matas AJ.  First Annual World Transplant Congress.  Boston, July 2006.

89. “Technical Failure of the Pancreas Graft After SPK Transplant: Are These Patients Good Candidates for Later Isolated Pancreas Transplant?”  Humar A, Sturdevant M, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  First Annual World Transplant Congress.  Boston, July 2006.

90. “Kidney after Pancreas (KAP) Transplants: Incidence and Outcome.”  Sutherland DER, Gruessner RW, Humar A, Kandaswamy R, Gruessner AC.  First Annual World Transplant Congress.  Boston, July 2006.

91. “Islet Allograft Survival in Type 1 Diabetes with Anti-Thymoglobulin, Etanercept, Cyclosporin, and Everlimus.”  Hering B, Parkey J, Fraga D, Ansite J, Friberg A, Zhang HJ, Nath D, Abdullah M, Guenther L, Papas K, Witson J, Kandaswamy R, Sutherland DER.  First Annual World Transplant Congress.  Boston, July 2006.

92. “A Multivariate Análisis of Risk Factors for Recurrent Acute Rejection (AR) in Recipients on a Steroid Avoidance Regimen.”  Humar A, Gillingham K, Kandaswamy R, Payne WD, Matas AJ.  American Transplant Congress.  San Francisco, May 2007.

93. “Prednisone-Free Maintenance Immunosuppression in Liver Transplant Recipients: Impact on Hepatitis C Recurrence and Posttransplant Diabetes.”  Humar A, Crotteau S, Gruessner AC, Gruessner R, Kandaswamy R, Payne WD, Lake J.  American Transplant Congress.  San Francisco, May 2007.

94.   “A comparison of outcomes for three laparoscopic donor nephrectomy (LDN) techniques: hand-assisted (HALDN) vs. pure (PLDN) vs. robotic-assisted (RALDN).” Hughes M, Gross E, Nguyen T, Garcia-Roca R, Gillingham K, Dunn T, Humar A, Gruessner R, Sutherland D, Matas A, Kandaswamy R. American Transplant Congress.  San Francisco, May 2007.

95. “Fourty-two Pediatric Liver Transplants for α-1-Antitrypsin Deficiency: Long-term Outcomes at a Single Center.”  Hughes M, Gruessner A, Gross E, Nguyen T, Garcia-Roca R, Sharp H, Kandaswamy R, Payne W, Humar A, Gruessner R.  International Liver Transplantation Society 13th International Congress, June 2007, Rio de Janeiro, Brazil.

96. “When and What to Transplant for Oxalosis: long-term results of 37 transplants kidney transplant alone [KTA], simultaneous liver and kidney transplant [SLK], and/or pre-emptive liver transplant prior to ESRD [PLT] at a single-center.”  Hughes M, Gruessner A, Gross E, Nguyen T, Garcia-Roca R, Kandaswamy R, Humar A, Payne W, Gruessner R.  International Liver Transplantation Society 13th International Congress, June 2007, Rio de Janeiro, Brazil.

97. “Kidney transplant (Tx) recipients with 10 yrs of graft survival: what happens next?”  Matas A, Gillingham K, Humar A, Dunn T, Kandaswamy R, Payne W, Sutherland D, Najarian J.  American Transplant Congress, May 31-June 4, 2008, Toronto, Ontario, Canada.

98. “A matched-paired analysis of adult living vs. deceased donor liver transplant.” Jie T, Gross E, Hughes M, Hill M, Kandaswamy R, Lake J, Payne W, Anderson D, Radosevich D, Humar A.  American Transplant Congress, May 31-June 4, 2008, Toronto, Ontario, Canada.

99. “Graft weight to recipient weight ration (GW/RW): how well does it predict outcome after partial graft liver transplant?”  Hill M, Hughes M, Gross E, Jie T, Lake J, Kandaswamy R, Payne W, Cohen M, Humar A.  American Transplant Congress, May 31-June 4, 2008, Toronto, Ontario, Canada.

100. “Prospective randomized trial of maintenance immunosuppression (IS) in prednisone (P)-free recipients: 5-year results.”  Kandaswamy R, Humar A, Dunn T, Gross E, Hughes M, Hill M, Jie T, Gillingham K, Matas A.  American Transplant Congress, May 31-June 4, 2008, Toronto, Ontario, Canada.

101. “Long-term graft survival (t ½) after rapid discontinuation of prednisone.”  Matas AJ, Gillingham KJ, Kandaswamy R, Dunn T, Payne W, Sutherland D, Humar A.  American Transplant Congress, May 31-June 4, 2008, Toronto, Ontario, Canada.

102. “Long term follow-up of >1000 kidney transplant recipients on prednisone (P)-free maintenance immunosuppression (IS).”  Humar A, Kandaswamy R, Payne W, Sutherland D, Kasiske B, Ibrahim H, Gillingham K, Matas A.  American Transplant Congress, May 31-June 4, 2008, Toronto, Ontario, Canada.

103. “Risk factors for acute rejection (AR) and graft loss (GL) after kidney transplantation with rapid discontinuation of prednisone (RPD).”  Gross EK, Hughes M, Hill M, Jie T, Gillingham K, Kandaswamy R, Humar A, Dunn T, Matas AJ.  American Transplant Congress, May 31-June 4, 2008, Toronto, Ontario, Canada.

Top of page

POSTER DISCUSSIONS

1. “Surgical complications requiring early relaparotomy in pancreas transplantation – comparison of FK vs. CsA era.” Humar A, Harmon J, Gruessner AC, Kandaswamy R, Granger D, Zhang K, Drangstveit MB, Sutherland DER, Gruessner RW, University of Minnesota. World Transplant Congress, Montreal , Canada.  July 1998.

2. “The impact (?) of HLA-ABDR match on chronic rejection (CR).”  Gillingham K, A. Matas, Humar A, Payne WD, Kandaswamy R, Dunn DL, Sutherland DER, Najarian JS.  International Congress of the Transplantation Society, Rome, August 2000.

3. “Pancreas after kidney transplantation (PAK):  an alternative to simultaneous pancreas and kidney transplantation.”  Gruessner RW, Sutherland DER, Dunn DL, Humar A, Kandaswamy R, Gruessner AC.  International Congress of the Transplantation Society, Rome, August 2000.

4. “Risk factors for graft loss differ by posttx interval.”  Matas AJ, Gillingham K, Kandaswamy R, Humar A.  American Society of Nephrology, 2000.

5. “Analysis of acute and chronic rejection patterns after pancreas transplant alone (PTA).” Humar A, Kandaswamy R, Ramcharan T, Paraskevas S, Meirelles R, Gruessner RW, Gruessner AC.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001.

6. “Cytokine gene polymorphisms (CGP) in “pancreas transplant alone” (PTA) Recipients – can they predict outcome?”  Kandaswamy R, Humar A, Gruessner AC, Gruessner RW, Hering B, Matas A, Sutherland DER.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001.

7. “Outcome after treatment of biopsy proven vs. presumptive acute rejection (AR) in kidney transplant recipients.”  Humar A, Kandaswamy R, Denny R, Paraskevas S, Gillingham K, Matas AJ.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

8. “The impact of elderly and pediatric donors on outcome after SPK transplant.”  Humar A, Kandaswamy R, Ramcharan T, Paraskevas S, Denny R, Gruessner RW, Gruessner AC, Sutherland DER.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

9. “Outcome of other organs recovered during in situ split liver procurements.”  Ramcharan T, Rogers M, Kandaswamy R, Sielaff T, Gruessner RW, Lake J, Payne WD, Humar A.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

10. “Split-liver transplant for 2 adult recipients:  an initial experience.”  Humar A, Kandaswamy R, Sielaff T, Gruessner RW, Knaak M, Lake J, Payne WD.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001. 

11. “Long-term cyclosporine immunosuppression:  is there nephrotoxicity in kidney transplant recipients?”  Paraskevas S, Denny R, Ramcharan T, Gillingham K, Kandaswamy R, Humar A, Matas AJ.  Second Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.  Chicago, Illinois, May 11-16, 2001.

12. “Current or historical donor specific sensitization (DSS) is a risk for poor outcome after kidney transplant (KTx).”  Dunn TB, Noreen H, Gillingham K, Kandaswamy R, Humar A, Sutherland DER, Matas A.  American Transplant Congress.  Toronto, Ontario, Canada, May 31-June 4, 2008.

13. “Health-related quality of life outcomes for kidney donors differ depending on type of laparoscopic donor nephrectomy (Pure P-LDN) vs. Hand-Assist (HA-LDN)).”  Hughes M, Jacobs C, Gross C, Baily B, Hill M, Jie T, Gross E, Dunn T, Humar A, Sutherland D, Matas A, Kandaswamy R.  American Transplant Congress.  Toronto, Ontario, Canada, May 31-June 4, 2008.

14. “Risk factors for clinically significant graft pancreatitis – is it the solution?”  Dunn TB, Del Coro C, Ferrer J, Kandaswamy R, Humar A, Radosevich DM, Sutherland DE.  American Transplant Congress.  Toronto, Ontario, Canada, May 31-June 4, 2008.

15. “Ten years of surgical wound infection surveillance in solid organ transplant: a single center experience: review of the microbiologic and epidemiological aspects of 4183 wounds.”  Statz C, Kandaswamy R, Beilman G.  American Transplant Congress.  Toronto, Ontario, Canada, May 31-June 4, 2008.

16. “Kidney transplant recipients have decreased cardiovascular death (vs. historical controls) after rapid discontinuation of prednisone.”  Matas AJ, Gillingham K, Humar A, Dunn T, Payne W, Sutherland D, Kandaswamy R.  American Transplant Congress.  Toronto, Ontario, Canada, May 31-June 4, 2008.

17. “Health-related quality of life after donating a liver.”  Radosevich D.M., Payne W.D., Lake J.R., Kandaswamy R, Humar A.  American Transplant Congress.  Toronto, Ontario, Canada, May 31-June 4, 2008.

18. “Three different types of simultaneous pancreas and kidney transplantation.”  Kobayashi T, Gruessner A.C., Grussner R.W.G., Humar A, Kandaswamy R, Tan M, Casingal V, Sturdevant M, Nguyen T, Garcia-Roca R, Gross E, Sutherland D.E.R.  American Transplant Congress.  Toronto, Ontario, Canada, May 31-June 4, 2008.

Top of page

POSTER PRESENTATIONS

1. “Vascular graft thrombosis after pancreas transplantation – comparison of the FK vs. CsA era.”  Kandaswamy R, Humar A, Gruessner AC, Granger D, Sutherland DER, Gruessner RW, University of Minnesota. World Transplant Congress, Montreal, Canada.  July 1998. 

2. “MRI is superior to angiography in the evaluation of living related simultaneous kidney pancreas donors.” Kandaswamy R, Stillman A, Granger D, Sutherland DER, Gruessner RW, University of Minnesota. World Transplant Congress, Montreal, Canada.  July 1998. 

3. “Clinical application of the two-layer [University of Wisconsin solution (UW) / Perflourochemical (PFC)] method of pancreas preservation before pancreas transplantation.” Matsumoto S, Hassoun A, Kandaswamy R, Hiraoka K, Sageshima J, Shibata S, Gilmore T, Tanioka Y, Kuroda Y, Sutherland DER.  American Society of Transplant Surgeons, Chicago, IL May 1999.

4. “Pancreatitis after pancreas transplants:  risk factors and consequences.”  Humar A, Hassoun A, Kandaswamy R, Parr E, Chmielewski B, Gruessner AC, Sutherland DER.  AST 18th Annual Meeting.  Chicago, May 1999. 

5. “Influence of current and remote B and T cell crossmatch on pancreas transplant.”  Hassoun A, Wijkstrom M, E Dittmar, Kandaswamy R, Moss A, Drangstveit MB, Noreen H, Segall M, Humar A, Sutherland DER. American Society of Transplant Surgeons, Chicago, IL May 1999.

6. “Pancreas retransplants: surgical risks and outcome.” Humar A, Kandaswamy R, Hassoun A, Drangstveit MB, Durand B, Gruessner AC, Sutherland DER. American Society of Transplantation, Chicago, IL May 1999.

7. “Intra-abdominal infections after pancreas transplantation: recent improvements in incidence and outcome.” Humar A, Gruessner AC, Harmon J, Kandaswamy R, Granger D, Drangstveit MB, Lynch S, Sutherland DER, Gruessner RW.  American Society of Transplantation, Chicago, IL May 1999.

8. “Surgical complication in bladder vs. enteric drained simultaneous pancreas kidney transplants.” Humar A, Kandaswamy R, Hassoun A, Drangstveit MB, Chmielewski B, Gruessner AC, Sutherland DER.  American Society of Transplant Surgeons, Chicago, IL May 1999.

9. “ABO incompatible, living unrelated, simultaneous kidney-pancreas transplantation: case report.” Kandaswamy R, Humar A, Wijkstrom M, Eastlund T, Hassoun A, Arrazola L, Prieto M, Moss A, Sutherland DER International Pancreas and Islet Transplant Association, Sydney, Australia. August 1999.

10. “Abdominal wall complications developing after kidney transplant.”  Humar A, Kandaswamy R, Uknis M, Paraskevas S, Gillingham K, Matas AJ.  American Society of Nephrology, 2000.

11. “Comparison of anti-thymocyte globulin (ATG) vs thymoglobulin (TMG) in pancreas transplantation.” Kandaswamy R, Humar A, Gruessner RW, Gruessner AC, Sutherland DER. Transplant 2000 Chicago.

12. “Bladder drainage is safer than enteric drainage in pancreas transplant recipients on peritoneal dialysis.”  Humar A, Kandaswamy R, Durand B, Arrazola L, Gruessner RW, Gruessner AC, Sutherland DER.  First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

13. “Pancreas after kidney (PAK) transplant:  a viable alternative to simultaneous pancreas kidney (SPK) transplant.”  Humar A, Kandaswamy R, Parr E, Drangstveit MB, Gruessner RW, Gruessner AC, Sutherland DER.  First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

14. “Surgical complications in obese pancreas transplant recipients.”  Humar A, Kandaswamy R, Drangstveit MB, Gruessner RW, Gruessner AC, Sutherland DER.  First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

15. “Comparison of single dose intraoperative antithymocyte globulin (ATG) vs. thymoglobulin (TMG) in pancreas (Px) transplants (Tx).”  Kandaswamy R, Humar A, Gruessner RW, Gruessner AC, Drangstveit MB, Sutherland DER.  First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

16. “ Superficial and deep wound infections developing after kidney transplant (KTx).”  Humar A, Kandaswamy R, Papalois B, Arrazola L, Gillingham K, Matas AJ.  First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2000.

17.  “Kidney (KD) and kidney-pancreas (KP) transplants in Jehovah’s Witnesses (JW) – a single-center experience with 50 transplants.”  Ramcharan T, Matas AJ, Gruessner RW, Sutherland DER, ¬Kandaswamy R.  Second Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, May 2001.

18. “Pancreas transplantation in recipients over 60 years of age.”  Ramcharan T, Paraskevas S, Denny R, Khwaja K, Kandaswamy R, Gruessner RW, Sutherland DER, Humar A.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

19. “Small bowel intramural site for xenogeneic islet transplantation in the pig-to-nonhuman primate model.”  Wijkstrom M, Sageshima J, Kirchhof N, Pilon KJ, Kandaswamy R, Gilmore T, Eckman E, Wahlberg J, Sutherland DER.  8th World Congress International Pancreas and Islet Transplantation Association.  Innsbruck, Austria, June 12-15, 2001.

20. “Laparoscopic nephrectomy in the obese donor.”  Asolati M, Khwaja K, Matas AJ, Gillingham K, Humar A, Gruessner RW, Sutherland DER, Kandaswamy R.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

21.  “Pancreas graft from older donors where cause of death is trauma – these organs work just fine!”  Humar A, Paraskevas S, Ramcharan T, Denny R, Khwaja K, Asolati M, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

22. “Health-related quality of life and satisfaction after kidney donation by open (ODN) vs. laparoscopic (LDN) technique.”  Radosevich D, Matas AJ, Dunn DL, McHugh L, Kandaswamy R.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

23. “A prospective randomized open-label trial of steroid avoidance (SA) vs. steroid withdrawal (SW) in simultaneous pancreas-kidney transplantation (SPK) using sirolimus/tacrolimus protocol.”  Kandaswamy R, Paraskevas S, Ramcharan T, Meirelles R, Gruessner AC, Humar A, Gruessner RW, Hayes M, Sutherland DER.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

24. “Pancreas transplantation in current T or B cell crossmatch positive recipients.” Khwaja K, Wijkstrom M, Gruessner AC, Humar A, Kandaswamy R, Noreen H, Sutherland DER, Gruessner RW.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

25. “Risk factors for rising creatinine in renal allografts with 1 and 3 year survival.”  Paraskevas S, Gillingham K, Humar A, Kandaswamy R, Matas AJ.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

26. “Predicting long-term kidney graft survival – can new trials be done?”  Paraskevas S, Gillingham K, Humar A, Kandaswamy R, Matas AJ.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

27. “Risk factors for 6 and 12 month serum creatinine levels – how can kidney graft survival be improved?”  Khwaja K, Gillingham K, Humar A, Payne WD, Matas AJ, Kandaswamy R.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

28. “Technical failures (TFs) after pancreas transplant – why grafts fail and the risk factors:  a multivariate analysis.”  Humar A,  Paraskevas S, Khwaja K, Denny R, Asolati M, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  Third Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Washington, D.C., April 2002.

29.  “Can pancreases from donors who underwent trauma splenectomy be used safely for transplantation?”  Asolati M, Meirelles R, Ramcharan T, Paraskevas S, Wijkstrom M, Humar A, Gruessner AC, Gruessner RW, Sutherland DER, Kandaswamy R.  XIX International Congress of the Transplantation Society.  Miami, August 2002 (publication).

30. “Pancreas transplantation in recipients over 60 years of age.”  Humar A, Ramcharan T, Paraskevas S, Denny R, Khwaja K, Asolati M, Kandaswamy R, Sutherland DER.  XIX International Congress of the Transplantation Society.  Miami, August 2002 (publication).

31. “Are double arteries of the left kidney preferable to single artery of the right kidney for laparoscopic donor nephrectomy?”  Asolati M, Khwaja K, Matas AJ, Gillingham K, Humar A, Gruessner RW, Sutherland DER, Dunn DL, Kandaswamy R.  XIX International Congress of the Transplantation Society.  Miami, August 2002 (publication).

32. “Steroid/immunosuppression-related complications in a protocol utilizing rapid discontinuation of steroids.”  Khwaja K, Kandaswamy R, Payne WD, Gruessner RW, Dunn DL, Najarian JS, Sutherland DER, Matas AJ.  XIX International Congress of the Transplantation Society.  Miami, August 2002 (publication).

33. “Pre-tx immunosuppression (IS) for pancreas (PX) transplants (TXS) alone (PTA) in non-uremic diabetic recipients.”  Sutherland DER, Gruessner RW, Humar A, Kandaswamy R, Dunn DL, Najarian JS, Gruessner AC.  XIX International Congress of the Transplantation Society.  Miami, August 2002.

34. “Impact of obesity on patient survival and technical failure rates after pancreas transplantation.”  Khwaja K, Gruessner AC, Sutherland DER, Humar A, Kandaswamy R, Gruessner RW.  XIX International Congress of the Transplantation Society.  Miami, August 2002.

35. “Risk factors for 6 and 12 month serum creatinine levels – how can kidney graft survival be improved?”  Khwaja K, Gillingham K, Humar A, Payne WD, Matas AJ, Kandaswamy R.  XIX International Congress of the Transplantation Society.  Miami, August 2002.

36. “Laparoscopic donor nephrectomy (LDN) – what’s in it for the recipient?”  Asolati M, Denny R, Matas AJ, Gillingham K, Humar A, Gruessner RW, Sutherland DER, Dunn DL, Kandaswamy R.  XIX International Congress of the Transplantation Society.  Miami, August 2002.

37. “Risk factors for rising creatinine in renal allografts with 1 and 3 year survival.”  Paraskevas S, Gillingham K, Humar A, Kandaswamy R, Matas AJ.  XIX International Congress of the Transplantation Society.  Miami, August 2002.

38. “Decreased incidence of hypothermia and peritoneal irrigation in laparoscopic donor nephrectomy using a filter – hydrator – heating device [Insuflow].”  Society of American Gastrointestinal Endoscopic Surgeons, Annual Scientific Session and Postgraduate Course, Los Angeles, CA.  March 2003.

39. “Single center, 5-year experience with laparoscopic donor nephrectomies (LDNs).”  Kandaswamy R, Gillingham K, McHugh L, Humar A, Gruessner RW, Sutherland DER, Dunn DL, Matas AJ.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

40. “A prospective randomized trial of steroid-free maintenance vs. delayed steroid withdrawal using a sirolimus/tacrolimus regimen in simultaneous pancreas-kidney transplants (SPK).”  Kandaswamy R, Khwaja K, Gruessner AC, Gruessner RW, Pulkrabeck L, Sutherland DER.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

41. “Pancreata from obese donors are suitable for islet isolation and transplantation.”  Matsumoto I, Sawada T, Nakano M, Liu B, Ansite J, Zhang HJ, Kandaswamy R, Sutherland DER, Hering B.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

42. “95% graft survival at 3 years posttransplant with steroid-free maintenance immunosuppression.”  Khwaja K, Asolati M, Harmon J, Gillingham K, Humar A, Kandaswamy R, Matas AJ.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

43. “”Right laparoscopic nephrectomies (LDNs) – are there additional risks?”  Harmon J, Matas AJ, Asolati M, Humar A, Gruessner RW, Sutherland DER, Dunn DL, Kandaswamy R.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

44. “Is obesity a risk factor for donor or recipient outcomes after laparoscopic donor nephrectomy (LDN)?”  Melancon JK, Matas AJ, Gillingham K, Humar A, Gruessner RW, Sutherland DER, Dunn DL, Kandaswamy R.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

45. “Perfluorochemical/University of Wisconsin solution (PFC/UW) is superior to UW for short-term preservation of human donor pancreas prior to islet isolation and transplantation.”  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

46. “Successful rapid discontinuation of prednisone in high-risk kidney transplant recipients.”  Khwaja K, Asolati M, Harmon J, Gillingham K, Humar A, Kandaswamy R, Matas AJ.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

47. “Acute rejection (AR) episodes occurring in kidney transplant recipients on a steroid-avoidance protocol – what are the consequences?”  Humar A, Harmon J, Asolati M, Payne WD, Gruessner RW, Sutherland DER, Kandaswamy R, Koushik R, Kasiske B, Gillingham K, Matas AJ.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

48. “Technical failure of the pancreas graft – what are the causes and how have they changed in the last 2 decades?”  Humar A, Khwaja K, Melancon JK, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DER.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

49. “Primary non-function [PNF] after kidney transplant – how common is it and what are the risk factors?”  Humar A, Harmon J, Asolati M, Kandaswamy R, Gruessner RW, Payne WD, Sutherland DER, Matas AJ.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

50. “Wound complications after kidney transplant – how much are the newer immunosuppression drugs playing a role?”  Humar A, Harmon J, Asolati M, Kandaswamy R, Payne WD, Gillingham K, Matas AJ.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

51. Delayed graft function (DGF) of the pancreas after pancreas transplant: risk factors, course, and prognosis.”  Humar A, Khwaja K, Melancon JK, Kandaswamy R, Gruessner RW, Sutherland DER, Gruessner AC.  Fourth Annual American Transplant Congress.  Washington, D.C.  June 2003.

52. “Liver failure in patients with cystic fibrosis (CF) – the importance of early liver transplant.”  Jie T, Sharp H, Lake, J, Gruessner RW, Kandaswamy R, Payne WD, Humar A.  Ninth Annual International Liver Transplantation Society Congress, Barcelona, Spain, June 18-21, 2003.

53. “CT-angiogram evaluation of living liver donors – intra-operative correlation with radiologic findings.  Rosen G, Gomes M, Sfaxi M, Williams K, Gruessner R, Kandaswamy R, Payne WD.  Fifth Annual American Transplant Congress.  Boston, May 2004.

54. “Calcineurin (CNI) withdrawal in liver transplant (LTX) recipients with late renal dysfunction – a viable and worthwhile option.”  Humar A, Horn K, Kalis A, Glessing B, GruessnerAC, Gruessner RW, Kandaswamy R, Payne WD, Lake J.  Fifth Annual American Transplant Congress.  Boston, May 2004.

55. “Pancreas transplantation provides excellent long-term insulin-free outcomes for patients with type 2 diabetes mellitus (DM).  Nath D, Gruessner AC, Kandaswamy R, Gruessner RW, Sutherland DER, Humar A.  Fifth Annual American Transplant Congress.  Boston, May 2004.

56. “Results with pancreas transplant in recipients with a history of major lower extremity ampuations.”  Humar A, Kandaswamy R, Harmon J, Melancon JK, Tan M, Dunn T, Gruessner RW, Sutherland DER, Gruessner AC.  Fifth Annual American Transplant Congress.  Boston, May 2004.

57. “Late anastomotic leaks in pancreas transplant (PTx) recipients – clinical characteristics and predisposing factors.”  Nath D, Gruessner AC,  Kandaswamy R, Gruessner RW, Sutherland DER, Humar A.  Fifth Annual American Transplant Congress.  Boston, May 2004.

58. “Delayed pancreas graft function in SPK recipients – its impact on kidney graft function.”  Humar A, Harmon J, Dunn T, Melancon JK, Tan M, Kandaswamy R, Gruessner RW, Matas AJ, Sutherland DER, Gruessner AC.  Fifth Annual American Transplant Congress.  Boston, May 2004.

59. “C4D+ acute rejection (AR) episodes in a steroid-avoidance protocol – a significant risk factor for decreased long-term graft survival.”  Humar A, Spong R, Casingal V, Sturdevant M, Kandaswamy R, Payne WD, Ibrahim H, Matas AJ.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

60. “The -238A allele of TNFα is associated with acute rejection in kidney transplantation.”  Oetting WS, Brott MJ, Pan W, Kandaswamy R, Matas AJ.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

61. “Laparoscopic donor nephrectomy: is obesity a risk factor for donor and recipient outcomes?”  Asolati M, Matas AJ, Gillingham K, Dunn T, Tan M, Casingal V, Sturdevant M, Humar A, Gruessner RW, Sutherland DER, Kandaswamy R.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

62. “Laparoscopic donor nephrectomy: is obesity a risk factor for donor and recipient outcomes?”  Asolati M, Matas AJ, Gillingham K, Dunn TB, Tan M, Casingal V, Sturdevant M, Humar A, Gruessner RW, Sutherland DER, Kandaswamy R.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

63. “Kidney transplant outcomes from older living donors – a twenty year experience.”  Sturdevant M, Matas AJ, Humar A, Gruessner RW, Sutherland DER, Najarian JS, Payne WD, Kandaswamy R.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

64. “Acute rejection – still a risk factor for long term outcome.”  Tan M, Dunn TB, Casingal V, Kandaswamy R, Humar A, Matas AJ.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

65. “Fungal infections in pancreas transplant recipients receiving alemtuzumab.”  Nath D, Kandaswamy R, Dunn TB, Gruessner RW, Sutherland DER, VanBurik J, Dunn DL, Humar A.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

66. “Early deaths (within 3 months) after pancreas transplant (PTx) – what are the causes and the risk factors?”  Humar A, Gruessner AC, Tan M, Dunn TB, Casingal V, Sturdevant M, Gruessner RW, Kandaswamy R, Sutherland DER.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

67. “Outcome of transplantation for primary hyperoxaluria: a single centre experience.” Tan M, Humar A, Kandaswamy R, Payne WD, Gruessner AC, Gruessner RW.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

68. “Twenty-year followup of kidney transplant recipients on long-term cyclosporine (CSA) therapy.”  Kandaswamy R,  Casingal V, Gillingham K, Humar A, Sutherland DER, Gruessner RW, Payne WD, Matas AJ.  Sixth Annual American Transplant Congress.  Seattle, May 2005.

69. “The -238A allele of TNF-α is associated with acute rejection in kidney transplantation.”  Oetting W, Brott M, Pan W, Kandaswamy R, Matas AJ.  .  Sixth Annual American Transplant Congress.  Seattle, May 2005.

70. “C4D  acute rejection (AR) episodes in a steroid-avoidance protocol – a significant risk factor for decreased long-term graft survival.” Humar A, Spong R, Casingal V, Sturdevant M, Kandaswamy R, Payne WD, Ibrahim H, Matas AJ.  .  Sixth Annual American Transplant Congress.  Seattle, May 2005.

71. “Stable Serum Creatining (Cr) Level with Long-Term Calcinuerin Inhibitors (CNIs).”  Kandaswamy R, Humar A, Gillingham K, Ibrahim H, Matas AJ.  First Annual World Transplant Congress.  Boston, July 2006.

72. “Laparoscopic Donor Nephrectomy (LDN): Robotic-Assisted (RALDN) vs. Pure (PLDN) vs. Hand-assisted (HALDN).”  Kandaswamy R, Casingal V, Sturdevant M, Nguyen T, Gross E, Humar A, Gruessner R, Sutherland D, Gillingham K, Matas AJ.  First Annual World Transplant Congress.  Boston, July 2006.

73. “Decreased Incidence of CMV Disease in Kidney Transplant Recipients Receiving a Steroid Avoidance Immunosuppression Regimen.”  Humar A, Sturdevant M, Garcia-Lorca R, Nguyen T, Gross E, Gillingham K, Kandaswamy R, Payne WD, Matas AJ.  First Annual World Transplant Congress.  Boston, July 2006.

74. “Benefits with a Steroid Avoidance (SA) Regimen in Liver Transplant Recipients.”  Humar A, Gruessner AC, Kandaswamy R, Gruessner RW, Payne WD, Lake J.  First Annual World Transplant Congress.  Boston, July 2006.

75. “PTDM or Acute Rejection (AR)—If You Had a Choice.”  Matas AJ, Gillingham K, Ibrahim H, Kandaswamy R, Sutherland DER, Gruessener RW, Humar A, Payne WD.  39th Annual Renal Week Meeting of the American Society of Nephrology, November 2006, San Diego.

76. “Acute Rejection – Still a Significant Risk Factor for Graft Loss.”  Matas AJ, Gillingham K, Payne WD, Kandaswamy R, Gruessner RW, Sutherland DER, Humar A.  39th Annual Renal Week Meeting of the American Society of Nephrology, November 2006, San Diego.

77. “6 Years of Prednisone (P)-Free Maintenance Immunosuppression.”  Humar A, Kandaswamy R, Payne WD, Gruessner RW, Sutherland DER, Kasiske B, Ibrahim H, Spong R, Gillingham K, Matas A.  39th Annual Renal Week Meeting of the American Society of Nephrology, November 2006, San Diego.

78. Rapid Discontinuation of Prednisone in Sensitized Recipients.”  Matas A, Humar A, Kandaswamy R, Sutherland DER, Gruessner RW, Payne WD, Gillingham K.  39th Annual Renal Week Meeting of the American Society of Nephrology, November 2006, San Diego.

79. “Acute Rejection – Still a Significant Risk Factor for Graft Loss.”  Humar A, Gillingham K, Payne WD, Kandaswamy R, Gruessner RW, Sutherland DER, Matas AJ.  American Transplant Congress.  San Francisco, May 2007.

80. “Long-term outcomes of liver transplantation in pediatric patients for biliary atresia (BA), fulminant hepatic failure (FHF), metabolic disorders (MD) and primary malignancy (PM).”  Hughes M, Gruessner A, Gross E, Nguyen T, Garcia-Roca R, Kandaswamy R, Humar A, Payne W, Gruessner R.  American Transplant Congress.  San Francisco, May 2007.

81. “Two-hundred Thirty Four Pediatric Liver Transplants at a Single-Center: long-term outcomes for biliary atresia (BA), fulminant hepatic failure (FHF), metabolic disorders (MD) and primary malignancy (PM).”  Hughes M, Gruessner A, Gross E, Nguyen T, Garcia-Roca R, Kandaswamy R, Humar A, Payne W, Gruessner R.  International Liver Transplantation Society 13th International Congress, June 2007, Rio de Janeiro, Brazil. (poster).

Top of page

INVITED LECTURES

1. “Laparoscopic nephrectomy for living kidney donation.” The Cutting Edge - New Frontiers in Transplantation, University of Minnesota, Minneapolis, May 2000.

2. “Organ and Islet Transplantation Update.” Community presentation.  Rice Lake, WI, Jan. 2001.

3.  “Islet transplantation update.”  National Meeting of the Association of Organ Procurement Organizations.  San Diego, Jan 2001.

4.  “Organ transplants to treat diabetes.” 4th Annual International Motor City Diabetes Symposium.  Wayne State University, Detroit, Michigan, October 2001.

5. “Advances in immunosuppression in pancreas transplantation.”  7th Congress of the Brazilian Organ Transplant Society.  Vitoria, Brasil, March 2001.

6. “Current status and future perspective of pancreas and islet transplantation.”  56th Annual Congress of the Japanese Society of Gastroenterological Surgery.  Akita, Japan, July 2001.

7. “Steroid sparing protocols.”  Transplant Immunosuppression 2001: the compleat care of the transplant recipient.  University of Minnesota, Minneapolis, October 2001.

8. “Current Status of Pancreas Islet Transplantation.”  The Cutting Edge – New Frontiers in Transplantation, University of Minnesota, Minneapolis, March 20, 2002.

9. “New Immunosuppression Protocols for Steroid Avoidance.”  Grand Rounds, Abbott Northwestern Hospital, Minneapolis, June 11, 2002.

10. “Pancreas Cell Preservation Process.”  International Society of Organ Preservation.  Washington, D.C., July 2002.

11. “Thymoglobulin Speaker Training and Advisory Meeting: Optimizing Transplantation Outcomes.  New Orleans, LA, November 8-10, 2002.

12. “University of Minnesota Islet Cell Transplant Program”, “Complications in Pancreas and Islet Cell Transplantation.” South-Eastern Organ Procurement Foundation Scientific Session.  Atlanta, March 19-20, 2003.

13. “Campath-1H in Kidney and Pancreas Transplantation.”  5th Annual Cutting Edge Conference, Minneapolis, April 7, 2003.

14.  “Current Controversies in Transplantation.”  Transplant Grand Rounds, Guy’s Hospital, London, England, May 8, 2003.

15. “Islet Cell Transplant.”  Renal Network of the Upper Midwest Annual Meeting, Milwaukee, October 10, 2003.

16. “Campath in Solid Organ Transplant Recipients.”  Department of Transplantation Grand Rounds, Abbott Northwestern Hospital.  Minneapolis, November 11, 2003.

17. “Clinical Pancreas Transplantation.”  Transplant Grand Rounds, Cleveland Clinic Hospital, Cleveland, February 24, 2004.

18. “New Immunosuppression Therapies.”  6th Annual Cutting Edge Conference, Minneapolis, April 7, 2004.

19. “Current Status of Pancreas and Islet Transplant.”  Apollo Health Foundation Meeting, Goa, India, January 2005.

20. “Beta Cell Replacement Therapy in Diabetes Mellitus.”  8th Congress of Turkish Transplant Society, Ankara, Turkey, June 2005.

21. “Update on Pancreas and Islet Transplant.” Five Lectures. 9th Congress of the Brazilian Organ Transplant Society, July 2005.

22. “Options for Beta Cell Replacement in Diabetes.”  Diabetes Update 2006, 3rd Annual Northwoods Diabetes Conference, University of Superior-Wisconsin, April 6, 2006.

23. “Current Status of Pancreas Transplantation.” LaSalle D, Leffall Surgical Society Meeting, Howard University, Washington D.C., March 2007.

24. “Risk of Donor Nephrectomy.”  Transplant Immunosuppression 2007: The Ongoing Search for Improvement, University of Minnesota, Minneapolis, MN, October 17, 2007.

25. “Current Status of Pancreas Transplantation.”  Surgical Grand Rounds, Lehigh Valley Hospital and Health Network, Allentown, PA, April 1, 2008.

Top of page

Return to Dr. Kandaswamy's CV